Stock Events

Stock Events

Keros Therapeutics (KROS) Q2 2026 Earnings

30AprConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-1.14

-0.82

-0.5

-0.18

Details

Expected EPS

-1.08625

Actual EPS

N/A

Surprise EPS

1.09

Surprise Percent

+100%

Description

Keros Therapeutics (KROS) will report earnings of for Q2 2026 on April 30, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.